中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

异甘草酸镁注射液与注射用还原型谷胱甘肽配伍的稳定性分析

李晓晖 文娱 晋文慧 洪专 曾美燕 陈伟珠

李晓晖, 文娱, 晋文慧, 洪专, 曾美燕, 陈伟珠. 异甘草酸镁注射液与注射用还原型谷胱甘肽配伍的稳定性分析[J]. 临床肝胆病杂志, 2016, 32(1): 143-147. DOI: 10.3969/j.issn.1001-5256.2016.01.028
引用本文: 李晓晖, 文娱, 晋文慧, 洪专, 曾美燕, 陈伟珠. 异甘草酸镁注射液与注射用还原型谷胱甘肽配伍的稳定性分析[J]. 临床肝胆病杂志, 2016, 32(1): 143-147. DOI: 10.3969/j.issn.1001-5256.2016.01.028
Li XiaoHui, Wen Yu, Jin WenHui, Hong Zhuan, Ceng MeiYan, Chen WeiZhu. Compatible stability of magnesium isoglycyrrhizinate injection and reduced glutathione for injection[J]. J Clin Hepatol, 2016, 32(1): 143-147. DOI: 10.3969/j.issn.1001-5256.2016.01.028
Citation: Li XiaoHui, Wen Yu, Jin WenHui, Hong Zhuan, Ceng MeiYan, Chen WeiZhu. Compatible stability of magnesium isoglycyrrhizinate injection and reduced glutathione for injection[J]. J Clin Hepatol, 2016, 32(1): 143-147. DOI: 10.3969/j.issn.1001-5256.2016.01.028

异甘草酸镁注射液与注射用还原型谷胱甘肽配伍的稳定性分析

DOI: 10.3969/j.issn.1001-5256.2016.01.028
详细信息
  • 中图分类号: R969.2

Compatible stability of magnesium isoglycyrrhizinate injection and reduced glutathione for injection

  • 摘要:

    目的考察异甘草酸镁(MgIG)注射液与注射用还原型谷胱甘肽(GSH)在室温条件下配伍的稳定性。方法采用高效液相色谱法测定MgIG注射液与注射用GSH在5%、10%葡萄糖溶液中配伍的浓度变化。结果 MgIG注射液与注射用GSH配伍液在0、0.5、1、1.5、2、4 h内浓度均无明显变化。结论 MgIG注射液与注射用GSH在5%、10%葡萄糖溶液中可以配伍使用,但应在4 h内用完。

     

  • [1]WANG P,WU XM.Therapeutic effect of magnesium isoglycyrrhizinate on carbon tetrachloride-induced chronic liver injury in rats[J].Chin J New Drugs Clin Remed,2004,23(12):833-836.(in Chinese)王佩,吴锡铭.异甘草酸镁对大鼠四氯化碳慢性肝损伤的治疗作用[J].中国新药与临床杂志,2004,23(12):833-836.
    [2]OU MH.Advances in pharmacological and clinical research on magnesium isoglycyrrhizinate[J].China Pharm,2010,19(15):83-85.(in Chinese)欧明洪.异甘草酸镁药理与临床研究进展[J].中国药业,2010,19(15):83-85.
    [3]YUAN PG,ZHANG DZ.Mechanism of action and clinical application of reduced glutathione[J].Drug Eval,2006,3(5):385-390.(in Chinese)袁平戈,张大志.还原型谷胱甘肽的作用机制及临床应用[J].药品评价,2006,3(5):385-390.
    [4]HE M,ZHAN M,LIU RM,et al.Systematic review on reduced glutathione in the treatment of drug-induced liver disease[J].China Pharm,2010,21(32):3049-3052.(in Chinese)何梅,占美,柳汝明,等.还原型谷胱甘肽治疗药物性肝病的系统评价[J].中国药房,2010,21(32):3049-3052.
    [5]DAI JH,IWATANI Y,ISHIDA T,et al.Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages[J].Immunology,2001,103(2):235-243.
    [6]ABE M,AKBAR F,HASEBE A,et al.Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis[J].J Gastroenterol,2003,38(10):962-967.
    [7]ZHANG Q,WU P,ZHANG JJ.The protective effect of the 18-αisomer of glycyrrhizic acid in human hepatocytes with chemical injury[J].Chin J Clin Pharmacol Ther,2011,16(12):1357-1360.(in Chinese)张群,吴培,张建军.18-α异构体甘草酸对化学损伤人肝细胞的保护作用[J].中国临床药理学与治疗学,2011,16(12):1357-1360.
    [8]CHEN WH,LU LG,ZENG MD,et al.Effect of magnesium isoglycyrrhizinate on the pmI iferation and oxidative stess of rat hepatic stellate cells in virtro[J].Chin J Hepatol,2006,14(6):426-430.(in Chinese)陈尉华,陆伦根,曾民德,等.异甘草酸镁对大鼠肝星状细胞增殖和氧应激的影响[J].中华肝脏病杂志,2006,14(6):426-430.
    [9]ZHONG CM,LI ZL,CHEN ZF.Clinical application of reduced glutathione[J].P Clin Med,2010,19(5A):325-328.(in Chinese)钟春梅,李正良,陈泽芳.还原型谷胱甘肽的临床应用[J].临床医药实践,2010,19(5A):325-328.
    [10]WANG YX,ZHANG XQ,WAN SZ.Compatible stability of magnesium isoglycyrrhizinate in 6 mixtures[J].Chin J Hosp Pharm,2008,28(20):1801-1803.(in Chinese)王艳霞,张喜全,万顺之.6种配伍液中异甘草酸镁的稳定性[J].中国医院药学杂志,2008,28(20):1801-1803.
    [11]ZHOU XQ,FANG J.Stability of reduced glutathione sodium in four different injections[J].China Pharm,2008,19(35):2759-2761.(in Chinese)周学琴,方静.注射用还原型谷胱甘肽钠与4种注射液的配伍稳定性考察[J].中国药房,2008,19(35):2759-2761.
  • 加载中
计量
  • 文章访问数:  2976
  • HTML全文浏览量:  15
  • PDF下载量:  411
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-05-07
  • 刊出日期:  2016-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回